Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Metropolis Healthcare Limited (NSE: METROPOLIS), ISIN INE112L01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
METROPOLIS last traded at ₹583.30 (+2.56%), with a 52-week range of ₹412.25 to ₹609.05 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 47.82%, FIIs 11.67%, DIIs 35.49%, mutual funds 33.09%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.